Last quarter (Q2 2022), Ondine Biomedical, Inc.'s total revenue was C$―, a decrease of ― from previous quarter. In Q2, Ondine Biomedical, Inc.'s net income was C$―. See Ondine Biomedical, Inc.’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 21	Dec 20	Dec 19
Total Revenue	-	C$ 2.57M	C$ 1.79M	C$ 464.00K
Cost of Revenue	-	C$ 1.31M	C$ 1.14M	C$ 328.00K
Gross Profit	-	C$ 1.25M	C$ 649.00K	C$ 136.00K
Operating Expense	-	C$ 18.77M	C$ 16.52M	C$ 14.16M
Operating Income	-	C$ -17.52M	C$ -15.87M	C$ -14.03M
Net Non Operating Interest Income Expense	-	C$ -1.20M	C$ -491.00K	C$ -179.00K
Other Income Expense	-	-	-	-
Pretax Income	-	C$ -50.09M	C$ -16.27M	C$ -13.99M
Tax Provision	-	C$ 0.00	C$ 0.00	-
Earnings From Equity Interest Net Of Tax	-	-	-	-
Net Income Common Stockholders	-	C$ -50.09M	C$ -16.27M	C$ -13.98M
Basic EPS	-	C$ -0.63	C$ -0.08	C$ -0.07
Diluted EPS	-	C$ -0.63	C$ -0.08	C$ -0.07
Basic Average Shares	-	C$ 79.64M	C$ 194.58M	C$ 194.58M
Diluted Average Shares	-	C$ 79.64M	C$ 194.58M	C$ 194.58M
Dividend Per Share	-	-	-	-
Total Operating Income As Reported	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-
Rent Expense Supplemental	-	C$ 129.00K	C$ 132.00K	-
Total Expenses	-	C$ 20.09M	C$ 17.66M	C$ 14.49M
Net Income From Continuing And Discontinued Operation	-	C$ -50.09M	C$ -16.27M	C$ -13.98M
Normalized Income	-	C$ -18.55M	C$ -16.05M	C$ -13.98M
Interest Expense	-	C$ 1.20M	C$ 491.00K	C$ 179.00K
EBIT	-	C$ -48.89M	C$ -15.78M	C$ -13.81M
EBITDA	-	C$ -48.37M	C$ -14.56M	C$ -12.59M

Currency in CAD

Ondine Biomedical, Inc. Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing